| P50 | author | Calum Sutherland | Q37834437 |
| | David K. Finlay | Q38589767 |
| P2093 | author name string | C J Hastie | |
| | H-K Liu | |
| | S Perrier | |
| | H McLauchlan | |
| | H S Hundal | |
| | C Lipina | |
| P2860 | cites work | Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta | Q24319688 |
| | Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3 | Q24528133 |
| | Glycogen synthase kinase-3 regulates IGFBP-1 gene transcription through the thymine-rich insulin response element | Q24793511 |
| | Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B | Q27860731 |
| | Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation | Q28140761 |
| | Conserved amino acids within CCAAT enhancer-binding proteins (C/EBP(alpha) and beta) regulate phosphoenolpyruvate carboxykinase (PEPCK) gene expression | Q28216935 |
| | Identification of a sequence in the PEPCK gene that mediates a negative effect of insulin on transcription | Q28240186 |
| | Molecular cloning and expression of glycogen synthase kinase-3/factor A | Q28569645 |
| | Insulin regulation of insulin-like growth factor-binding protein-1 gene expression is dependent on the mammalian target of rapamycin, but independent of ribosomal S6 kinase activity | Q28574617 |
| | Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification | Q28640539 |
| | Wnt signalling: pathway or network? | Q33712586 |
| | Insulin-induced up-regulated uncoupling protein-1 expression is mediated by insulin receptor substrate 1 through the phosphatidylinositol 3-kinase/Akt signaling pathway in fetal brown adipocytes | Q78785297 |
| | Effects of Wnt signaling on brown adipocyte differentiation and metabolism mediated by PGC-1alpha | Q33823104 |
| | Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis | Q33896013 |
| | Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression | Q33945272 |
| | Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase | Q33960787 |
| | Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo | Q34179931 |
| | Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase | Q34251769 |
| | GSK3 takes centre stage more than 20 years after its discovery | Q34374129 |
| | Impaired Energy Homeostasis in C/EBPα Knockout Mice | Q34662358 |
| | GSK3 inhibitors: development and therapeutic potential | Q35790372 |
| | Pharmacological inhibitors of glycogen synthase kinase 3. | Q35960333 |
| | Phosphorylation of C/EBPalpha inhibits granulopoiesis | Q36221878 |
| | Disruption of the c/ebp alpha gene in adult mouse liver | Q36573179 |
| | Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes | Q37515269 |
| | Insulin regulates transcription of the CCAAT/enhancer binding protein (C/EBP) alpha, beta, and delta genes in fully-differentiated 3T3-L1 adipocytes | Q38299816 |
| | Glucocorticoids and insulin regulate expression of the human gene for insulin-like growth factor-binding protein-1 through proximal promoter elements. | Q38301458 |
| | Metabolic response of mice to a postnatal ablation of CCAAT/enhancer-binding protein alpha | Q38321001 |
| | The alpha-isoform of the CCAAT/enhancer-binding protein is required for mediating cAMP responsiveness of the phosphoenolpyruvate carboxykinase promoter in hepatoma cells | Q38359300 |
| | CREB (cAMP response element binding protein) and C/EBPalpha (CCAAT/enhancer binding protein) are required for the superstimulation of phosphoenolpyruvate carboxykinase gene transcription by adenoviral E1a and cAMP. | Q40841380 |
| | A tripartite array of transcription factor binding sites mediates cAMP induction of phosphoenolpyruvate carboxykinase gene transcription and its inhibition by insulin | Q41024622 |
| | A novel DNA/protein complex interacts with the insulin-like growth factor binding protein-1 (IGFBP-1) insulin response sequence and is required for maximal effects of insulin and glucocorticoids on promoter function | Q41118941 |
| | Differential expression of insulin-like growth factor-I and insulin-like growth factor binding protein-1 in the diabetic rat | Q41139478 |
| | Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes | Q41743578 |
| | Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling | Q42032355 |
| | GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons. | Q42141352 |
| | Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats | Q42435439 |
| | Conservation of an insulin response unit between mouse and human glucose-6-phosphatase catalytic subunit gene promoters: transcription factor FKHR binds the insulin response sequence | Q42477315 |
| | Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase. | Q42797617 |
| | Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats | Q44155466 |
| | Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus | Q44688564 |
| | Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle | Q45238627 |
| | cDNA cloning and properties of glycogen synthase kinase-3. | Q48829897 |
| | Role of glucokinase and glucose-6-phosphatase in the acute and chronic regulation of hepatic glucose fluxes by insulin. | Q51598203 |
| | The role of C/EBP genes in adipocyte differentiation. | Q52182559 |
| | Role of the isoforms of CCAAT/enhancer-binding protein in the initiation of phosphoenolpyruvate carboxykinase (GTP) gene transcription at birth. | Q52192519 |
| | The α-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro | Q58450063 |
| | Insulin sensitization in diabetic rat liver by an antihyperglycemic agent | Q72618775 |
| | Hormonal regulation of the phosphoenolpyruvate carboxykinase gene. Role of specific CCAAT/enhancer-binding protein isoforms | Q73463006 |
| | Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins | Q74061501 |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 14 | |
| P577 | publication date | 2006-04-06 | |
| P1433 | published in | BMC Molecular Biology | Q15760954 |
| P1476 | title | Functional characterisation of the regulation of CAAT enhancer binding protein alpha by GSK-3 phosphorylation of Threonines 222/226. | |
| P478 | volume | 7 | |